WOSB Stock Overview
Wolters Kluwer N.V. provides professional information, software solutions, and services in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Wolters Kluwer N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €139.96 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | 0.26 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| WOSB | CH Professional Services | CH Market | |
|---|---|---|---|
| 7D | 0% | 0.9% | -0.4% |
| 1Y | n/a | 17.9% | -4.8% |
Return vs Industry: Insufficient data to determine how WOSB performed against the Swiss Professional Services industry.
Return vs Market: Insufficient data to determine how WOSB performed against the Swiss Market.
Price Volatility
| WOSB volatility | |
|---|---|
| WOSB Average Weekly Movement | n/a |
| Professional Services Industry Average Movement | 4.9% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.4% |
| 10% least volatile stocks in CH Market | 2.0% |
Stable Share Price: WOSB has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine WOSB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1836 | 21,056 | Nancy McKinstry | wolterskluwer.com |
Wolters Kluwer N.V. provides professional information, software solutions, and services in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally. The company operates through Health; Tax & Accounting; Financial & Corporate Compliance; Legal & Regulatory; and Corporate Performance & ESG segments. The Health segment offers clinical technology and evidence-based solutions that drive effective decision-making and improved outcomes across healthcare.
Wolters Kluwer N.V. Fundamentals Summary
| WOSB fundamental statistics | |
|---|---|
| Market cap | CHF33.34b |
| Earnings (TTM) | CHF981.27m |
| Revenue (TTM) | CHF5.44b |
34.0x
P/E Ratio6.1x
P/S RatioIs WOSB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WOSB income statement (TTM) | |
|---|---|
| Revenue | €5.58b |
| Cost of Revenue | €1.58b |
| Gross Profit | €4.01b |
| Other Expenses | €3.00b |
| Earnings | €1.01b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jul 31, 2024
| Earnings per share (EPS) | 4.23 |
| Gross Margin | 71.78% |
| Net Profit Margin | 18.03% |
| Debt/Equity Ratio | 198.8% |
How did WOSB perform over the long term?
See historical performance and comparison